| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Vincerx Pharma, Inc.
13G/A
VINC · 92731L106
|
0% |
7/29/2025
Event 1/29/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.